Health

Results: 6913-6924 of 9373

PR Newswire associated0

dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty

Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis

PR Newswire associated0

Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging

GlobeNewswire associated0

Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year

Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting

GlobeNewswire associated0

KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering

CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC

Business Wire logo

Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma

GlobeNewswire associated0

EAACI Congress Kicks Off in Valencia, Spain

Business Wire logo

Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Business Wire logo

Stallergenes Greer Showcases New Data for Food and Respiratory Immunotherapy at 2024 EAACI Congress

e4life devices (Photo: e4life)

e4life, the New Frontier in the Battle Against Viruses Has Arrived in the United Kingdom Thanks to a Patented Italian Device Which Uses Electromagnetic Waves to Inactivate Them